Springer Nature
Browse
13058_2016_749_MOESM1_ESM.pdf (573.69 kB)

Additional file 1: Figure S1. of PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells

Download (573.69 kB)
journal contribution
posted on 2016-09-23, 05:00 authored by Jessica Byerly, Gwyneth Halstead-Nussloch, Koichi Ito, Igor Katsyv, Hanna Irie
PRKCQ downregulation in MDA-231-LucD3H2LN cells results in G2-M arrest. Triple-negative MDA-231-LucD3H2LN cells were infected with PRKCQ shRNA lentiviral supernatant for 48 hours. Cells were fixed and stained with PI, and cell-cycle profile analysis was performed using flow cytometry. Results from four independent experiments were averaged. Figure S2 PRKCQ shRNA has no effect on growth of MDA231 cells that do not express detectable PKCθ protein. MDA231 cells expressing empty vector (EV) or PRKCQ shRNA (54) were grown in 3-D cultures for 7 days. (PDF 573 kb)

Funding

Susan G. Komen for the Cure (US)

History